Survival prediction for CA19-9 non-producers with resected pancreatic cancer
Open Access
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Characteristics and prognosis of patients with pancreatic adenocarcinoma not expressing CA19-9: Analysis of the National Cancer DatabasePancreatology, 2024
- Can preoperative Carbohydrate Antigen 19-9 predict metastatic pancreatic cancer? Results of a systematic review and meta-analysisHPB, 2024
- Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled AnalysisTranslational Oncology, 2019
- New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancerPancreatology, 2018
- Distribution of Lewis and Secretor polymorphisms and corresponding CA19‐9 antigen expression in a Chinese populationFEBS Open Bio, 2017
- The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years AfterSurgery, 2017
- Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database StudyJournal of the American College of Surgeons, 2016
- CA 19-9: Biochemical and Clinical Aspects2015
- Delayed gastric emptying (DGE) after pancreatic surgery: A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS)Surgery, 2007
- Postpancreatectomy hemorrhage (PPH)–An International Study Group of Pancreatic Surgery (ISGPS) definitionSurgery, 2007